Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04745624 · ClinicalTrials.gov registry record
Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 200
- Enrollment target
NCT04745624: Completed study, sponsored by Yale University.
NCT04745624 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04745624 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
To study the patient characteristics and outcomes associated with the real-world use of manual compression vs. vascular closure devices (VCDs) after common femoral artery (CFA) percutaneous access for coronary and endovascular interventions. An institutional procedural database, based on electronic medical record information will be abstracted to collect this information.
Primary Outcome
No evidence of bleeding after device use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-08-20 |
| Est. Completion | 2021-12-01 |
What the finished NCT04745624 record still lists
NCT04745624 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04745624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04745624 about?
NCT04745624 is a clinical study titled "Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease". To study the patient characteristics and outcomes associated with the real-world use of manual compression vs. vascular closure devices (VCDs) after common femoral artery (CFA) percutaneous access for coronary and endovascular interventions. An institutional procedural database, based on electronic ...
What is the current status of trial NCT04745624?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2020-08-20. Estimated completion is 2021-12-01.
Who is sponsoring clinical trial NCT04745624?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI